Does METFORMIN\SITAGLIPTIN Cause Malignant neoplasm progression? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Malignant neoplasm progression have been filed in association with METFORMIN\SITAGLIPTIN. This represents 0.1% of all adverse event reports for METFORMIN\SITAGLIPTIN.
10
Reports of Malignant neoplasm progression with METFORMIN\SITAGLIPTIN
0.1%
of all METFORMIN\SITAGLIPTIN reports
6
Deaths
6
Hospitalizations
How Dangerous Is Malignant neoplasm progression From METFORMIN\SITAGLIPTIN?
Of the 10 reports, 6 (60.0%) resulted in death, 6 (60.0%) required hospitalization, and 1 (10.0%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for METFORMIN\SITAGLIPTIN. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does METFORMIN\SITAGLIPTIN Cause?
Blood glucose increased (709)
Acute kidney injury (616)
Lactic acidosis (557)
No adverse event (539)
Diarrhoea (513)
Inappropriate schedule of drug administration (469)
Product dose omission issue (452)
Pancreatic carcinoma (431)
Drug ineffective (384)
Nausea (378)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which METFORMIN\SITAGLIPTIN Alternatives Have Lower Malignant neoplasm progression Risk?
METFORMIN\SITAGLIPTIN vs METFORMIN\VILDAGLIPTIN
METFORMIN\SITAGLIPTIN vs METHADONE
METFORMIN\SITAGLIPTIN vs METHAMPHETAMINE
METFORMIN\SITAGLIPTIN vs METHENAMINE HIPPURATE
METFORMIN\SITAGLIPTIN vs METHIMAZOLE